000 | 02653cam a22004215a 4500 | ||
---|---|---|---|
999 |
_c3722 _d3722 |
||
001 | 15675258 | ||
003 | SUN | ||
005 | 20180807121527.0 | ||
008 | 090128s2008 sz a b i000 0 eng | ||
010 | _a 2009388567 | ||
020 | _a9789241547499 | ||
020 | _a9241547499 | ||
035 | _a(OCoLC)ocn300063303 | ||
040 |
_aHNC _cSUNLIB _dGUA _dYDXCP _dIXA _dCOD _dHL8 _dDLC |
||
042 | _alccopycat | ||
050 | 0 | 0 |
_aRM301.9 _b.P73 2008 |
082 |
_a372.7/ _bWHO |
||
245 | 0 | 2 | _aA Practical handbook on the pharmacovigilance of antimalarial medicines. |
260 |
_aGeneva, Switzerland : _bWorld Health Organization, _cc2008. |
||
300 |
_aviii, 108 p. : _bill. (some col.) ; _c22 cm. |
||
505 | 0 | _aA. Introduction -- B. Passive or active pharmacovigilance? -- C. Spontaneous reporting -- D. Cohort event monitoring -- E. Data processing -- F. Special types of event -- G. Relationship/causality assessment -- H. Signal identification -- I. Strengthening the signal -- J. Identifying risk factors -- K. Analyses -- L. Differences between spontaneous reporting and cohort event monitoring -- M. Organization -- N. Communication -- Annex. | |
520 | _aThis publication is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It provides information on spontaneous reporting of adverse drug reactions as a complement to other WHO publications. In addition, it provides details on how to conduct cohort event monitoring, which is a method of active safety surveillance collecting information on all adverse events occurring after treatment. It also details how to perform causality assessment and signal identification, applicable to both methods of surveillance.--Publisher's description. | ||
530 | _aAlso available online. | ||
650 | 0 |
_aDrug monitoring. _99144 |
|
650 | 0 |
_aAntimalarials _xSide effects. _99145 |
|
650 | 2 |
_aAdverse Drug Reaction Reporting Systems. _99146 |
|
650 | 2 |
_aAntimalarials _xadverse effects. _99147 |
|
650 | 2 |
_aAntimalarials _xstandards. _99148 |
|
650 | 2 |
_aDrug Monitoring. _99149 |
|
650 | 2 |
_aDrug Utilization Review _xmethods. _99150 |
|
650 | 2 |
_aPharmacoepidemiology _xmethods. _99151 |
|
650 | 2 |
_aProduct Surveillance, Postmarketing. _99152 |
|
710 | 2 |
_aWorld Health Organization. _94691 |
|
856 | 4 | 1 |
_uhttp://www.who.int/medicines/areas/quality_safety/safety_efficacy/handbook_antimalarialpharmvigilance.pdf _zConnect to online resource |
906 |
_a7 _bcbc _ccopycat _d3 _encip _f20 _gy-gencatlg |
||
942 |
_2ddc _cBK |